Literature DB >> 20122763

Derivatives of benzimidazole pharmacophore: synthesis, anticonvulsant, antidiabetic and DNA cleavage studies.

Ramya V Shingalapur1, Kallappa M Hosamani, Rangappa S Keri, Mallinath H Hugar.   

Abstract

In seeking broad spectrum pharmacological activities of benzimidazole derivatives, a group of 4-thiazolidinones 5(a-j) and 1,3,4-oxadiazoles 6(a-j) containing 2-mercapto benzimidazole moiety were synthesized and screened for in vivo anticonvulsant activity by Maximal Electroshock (MES) model and antidiabetic activity using Oral Glucose Tolerance Test (OGTT). Compounds (5c), (5d), (5g) and (5i) exhibited potent anticonvulsant results and (6c), (6d), (6h) and (6i) showed excellent antidiabetic activities and also pharmacophore derived from active molecules suggested that presence of -OH group was a common feature in all active compounds. In DNA cleavage studies, compound (5d) cleaved DNA completely as no trace of DNA was found. On the other hand, a sharp streak was found for compounds (5c), (6a) and (6d). Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122763     DOI: 10.1016/j.ejmech.2010.01.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  21 in total

1.  A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.

Authors:  Jin-Cherng Lien; Chi-Li Chung; Tur-Fu Huang; Tsung-Chia Chang; Kuan-Chung Chen; Ging-Yan Gao; Ming-Jen Hsu; Shiu-Wen Huang
Journal:  Br J Pharmacol       Date:  2019-09-15       Impact factor: 8.739

2.  Synthesis, characterisation and evaluation of N-mannich bases of 2-substituted Benzimidazole derivatives.

Authors:  Sekar Vinoth Kumar; Mohan Raj Subramanian; Santhosh Kumar Chinnaiyan
Journal:  J Young Pharm       Date:  2013-12-11

3.  Benzimidazole derivative M084 extends the lifespan of Caenorhabditis elegans in a DAF-16/FOXO-dependent way.

Authors:  Ai-Jun Ding; Gui-Sheng Wu; Bin Tang; Xuechuan Hong; Michael X Zhu; Huai-Rong Luo
Journal:  Mol Cell Biochem       Date:  2016-11-16       Impact factor: 3.396

4.  Rapid, Microwave Accelerated Synthesis of [1,2,4]Triazolo[3,4-b][1,3,4]oxadiazoles from 4-Acylamino-1,2,4-Triazoles.

Authors:  Stesphanie L Breunig; Margaret E Olson; Daniel A Harki
Journal:  Tetrahedron Lett       Date:  2016-07-29       Impact factor: 2.415

5.  2-Methyl-5-nitro-1H-benzimidazole monohydrate.

Authors:  Raza Murad Ghalib; Rokiah Hashim; Othman Sulaiman; Ching Kheng Quah; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-25

6.  Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases.

Authors:  Vijay Sai Krishna Cheerala; Prasanth Ghanta; Sundaresan Chittor Neelakantan
Journal:  RSC Adv       Date:  2021-12-10       Impact factor: 4.036

7.  Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats

Authors:  Burak Dik; Devran Coşkun; Emre Bahçivan; Kamil Üney
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

8.  Synthesis and Pharmacological Activities of Some New 5-Substituted-2-mercapto-1,3,4-oxadiazoles.

Authors:  Shobha R Desai; U Laddi; Rajani S Bennur; P A Patil; S Bennur
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

9.  Design and Synthesis of New Benzimidazole and Pyrimidine Derivatives as α-glucosidase Inhibitor.

Authors:  Akbar Mobinikhaledi; Behvar Asghari; Mahsa Jabbarpour
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Novel 4-thiazolidinone derivatives as agonists of benzodiazepine receptors: Design, synthesis and pharmacological evaluation.

Authors:  Mehrdad Faizi; Reza Jahani; Seyed Abbas Ebadi; Sayyed Abbas Tabatabai; Elham Rezaee; Mehrnaz Lotfaliei; Mohsen Amini; Ali Almasirad
Journal:  EXCLI J       Date:  2017-01-13       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.